Drug Profile
CO 26749
Alternative Names: GMA 839; WAY 141839Latest Information Update: 29 Sep 2006
Price :
$50
*
At a glance
- Originator Purdue Pharma
- Developer Purdue Pharma; Wyeth
- Class Anxiolytics; Pregnanes
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 28 Sep 2006 Discontinued - Preclinical for Anxiety disorders in USA (unspecified route)
- 23 Dec 2002 This compound is still in active development
- 20 Mar 2002 American Home Products and its subsidiary Wyeth-Ayerst are both now called Wyeth